European markets turn lower after starting the new trading week with positive momentum

European markets turn lower after starting the new trading week with positive momentum


A stock trader looks at his monitors in the trading room of the Frankfurt Stock Exchange. Worries about a new coronavirus mutation in southern Africa have dealt a major blow to the German stock market. 

Arne Dedert | Picture Alliance | Getty Images

LONDON — European stocks started the new trading week on a positive note, buoyed by gains in Asia overnight and last Friday’s rally on Wall Street, before quickly paring gains.

The pan-European Stoxx 600 index opened 0.56% higher Monday but pared gains to turn lower, down 0.2% in early trades. Banks and household goods are currently the only sectors in positive territory, up 0.2% and 0.4%, respectively.

Looking at individual stocks, shares of Rio Tinto were down 0.26% after the miner confirmed it was in talks to buy lithium producer Arcadium Lithium.

Shares of Italgas were down 0.4% after Italy’s biggest gas distributor said it expected double-digit growth in net income and core profit as part of a new plan, Reuters reported. This comes after it signed a 5.3 billion euro ($5.8 billion) deal to acquire rival 2i Rete Gas on Saturday.

On the data front in Europe Monday, the U.K.’s Halifax House Price Index showed British house prices rose in September at the fastest annual pace since November 2022.

Other data showed euro zone retail sales edged up in August, up 0.2% from the previous month and in line with a Reuters poll.  Jack Allen-Reynolds, deputy chief euro zone economist at Capital Economics noted Monday that “the available data suggest that euro-zone household spending was subdued in the third quarter and may well have fallen.”

European stocks looked set to continue the positive sentiment seen at the close of trade last week, with markets getting a boost from the latest U.S. jobs report that exceeded expectations. Nonfarm payrolls data showed the U.S. economy added 254,000 jobs in September, ahead of the 150,000 estimated by economists polled by Dow Jones.

Stock picks and investing trends from CNBC Pro:

Asia-Pacific markets mostly climbed overnight, led by Japan’s Nikkei 225 rising almost 2% as investors look ahead to a week of central bank decisions from around the region, including from the Bank of Korea, the Reserve Bank of New Zealand and the Reserve Bank of India.

U.S. stock futures were calm on Sunday evening as Wall Street looks to keep the momentum from Friday’s rally following a stronger-than-expected jobs report on Friday that gave more support to the idea that the Federal Reserve may pull off a “soft landing” for the U.S. economy.



Source

Several killed after fire in Swiss ski resort bar
World

Several killed after fire in Swiss ski resort bar

Police officers walk at the site of an explosion that ripped through a bar in Crans-Montana on January 1, 2026. Several people were killed and others injured when an explosion ripped through a bar in the luxury Alpine ski resort town of Crans Montana, Swiss police said early on January 1. Maxime Schmid | Afp […]

Read More
U.S. grants TSMC annual licence to import U.S. chipmaking tools into China
World

U.S. grants TSMC annual licence to import U.S. chipmaking tools into China

TSMC offices in San Jose, California, on April 18, 2024. Bloomberg | Bloomberg | Getty Images The U.S. government has granted an annual licence to Taiwan Semiconductor Manufacturing to import U.S. chip manufacturing equipment to its facilities in Nanjing, China, the chipmaker said on Thursday. The approval “ensures uninterrupted fab operations and product deliveries,” the […]

Read More
Novo Nordisk enters 2026 on the defense as it faces a ‘must-win’ battle in the U.S. market
World

Novo Nordisk enters 2026 on the defense as it faces a ‘must-win’ battle in the U.S. market

Still life of the big three injectable prescription weight loss medicines. Ozempic, Victoza and Wegovy. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) Ucg | Universal Images Group | Getty Images Novo Nordisk’s shift from a market darling to a serious underperformer has set the stage for a transitional 2026 as the Danish drugmaker […]

Read More